Leaflet INTANZA 9mcg/tulpina injection suspension


Indicated for: prevention of influenza

Route of administration: injectable

Substance: inactivated influenza vaccine (vaccine)

ATC: J07BB02 (Antiinfectives for systemic use | Viral vaccines | Influenza vaccines)

The inactivated influenza vaccine is used to prevent seasonal flu, a viral illness caused by influenza viruses of types A and B. The vaccine contains inactivated influenza viruses that cannot cause the disease but stimulate the immune system to produce specific antibodies against influenza viruses.

The vaccine is administered intramuscularly or subcutaneously, usually annually, and is recommended for all individuals over 6 months of age, especially those in high-risk groups such as the elderly, pregnant women, individuals with chronic illnesses, and healthcare workers.

Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.

The inactivated influenza vaccine is an important preventive measure for reducing the incidence and severity of seasonal flu, helping to protect public health and alleviate the burden on healthcare systems.

General data about INTANZA 9mcg/tulpina

  • Substance: inactivated influenza vaccine
  • Date of last drug list: 01-06-2017
  • Commercial code: W63398001
  • Concentration: 9mcg / strain
  • Pharmaceutical form: injection suspension
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for inactivated influenza vaccine

Concentrations available for inactivated influenza vaccine

  • 15mcg/strain
  • 9mcg/strain
  • min. 15mcg of each vaccine
  • min. 15mcgof each vaccine
  • min.15mcgHA ptr. fiecare tip